# Efficacy of ArTiMist™ in Children

> **NCT01047436** · PHASE2 · COMPLETED · sponsor: **Proto Pharma Ltd** · enrollment: 31 (actual)

## Conditions studied

- Falciparum Malaria

## Interventions

- **DRUG:** Quinine
- **DRUG:** Artemether

## Key facts

- **NCT ID:** NCT01047436
- **Lead sponsor:** Proto Pharma Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2011-01-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01047436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01047436, "Efficacy of ArTiMist™ in Children". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01047436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*